Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CareOnTIME: Dual-release hydrocortisone in CAH
NCT03760835Phase 4Recruiting
- Sponsor
- University of Naples Federico II
- Start
- Aug 2016
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone in congenital adrenal hyperplasia (CAH), sponsored by University of Naples Federico II. Started Aug 2016; status: recruiting.
02
Drugs
hydrocortisone
03
Conditions
congenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on NCT03760835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03760835.